| |
| |
|
| Insider
Information: |
Klausner Arthur J |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
49,433 |
|
|
Indirect Shares
|
3,055,394 |
|
|
| Direct
Value |
$22,444 |
|
|
|
Indirect Value
|
$2,221,883 |
|
|
| Total
Shares |
3,104,827 |
|
|
| Total
Value |
$2,244,326 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
Director |
2004-03-31 |
18,570 |
|
0 |
Premium* |
|
|
Monopar Therapeutics |
MNPR |
Director |
2023-12-31 |
30,863 |
2023-12-31 |
3,055,394 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNPR |
Monopar Therapeutics |
Director |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
30,863 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Director |
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
28,330 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Director |
• • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,534 |
25,797 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
Director |
• • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
20,730 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
17,871 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
15,012 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
12,153 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
751 |
9,294 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2021-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
751 |
8,543 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2021-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
752 |
7,792 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2021-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
751 |
7,040 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
322 |
6,289 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2020-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
322 |
5,967 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
323 |
5,645 |
0 |
- |
|
| MNPR |
Monopar Therapeutics |
|
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
322 |
5,322 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2004-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,570 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
